Abstract:Calcium silicate cement has attracted much attention for bone defect repair and regeneration due to its osteogenic properties. Biomaterial-associated infections and washout have become a common clinical problem. In order to enhance the antibacterial and washout performance of calcium silicate cement to meet clinical needs, different types of chitosan, including chitosan polysaccharide (CTS), quaternary ammonium chitosan (QTS), and chitosan oligosaccharide (COS), as a liquid phase were added to the calcium silicate powder. The physicochemical properties, in vitro bioactivity, antibacterial efficacy, and osteogenic effects (MG63 cells) of the cement were evaluated. Antibacterial activity was conducted with Gram-negative Escherichia coli (E. coli) and a Gram-positive Staphylococcus aureus (S. aureus) bacteria. The amount of intracellular reactive oxygen species (ROS) produced in the bacteria cultured with the chitosan solution was also detected. The experimental results showed that the chitosan additive did not affect the crystalline phase of calcium silicate cement, but increased the setting time and strength of the cement in a concentration-dependent manner. Within the scope of this study, CTS and QTS solutions with a concentration of not <1 wt% improved the washout resistance of the control cement, while the COS solutions failed to strengthen the cement. When soaked in simulated body fluid (SBF) for 1 day, all cement samples formed apatite spherules. As the soaking time increased, the diametral tensile strength of all cements decreased and the porosity increased. The assays of MG63 cell function showed lower osteogenic activity of osteoblastic cells grown on the surfaces of the chitosan-incorporated cements in comparison with the control cement without chitosan. At the same 1% concentration, compared with QTS and COS cement, CTS cement had lower cell attachment, proliferation, differentiation, and mineralization. Conversely, the CTS cement resulted in the highest bacteriostasis ratio among the three hybrid cements against two bacteria. The ROS production followed the order of CTS > QTS > COS at the same 1% concentration. In conclusion, calcium silicate cement with 1% QTS may be a viable candidate for bone defect repair in view of anti-washout performance, setting time, antibacterial activity, and osteogenic activity shown in this study.

Properties of Anti-Washout-type Calcium Silicate Bone Cements Containing Gelatin

In vitro and in vivo osteogenesis of gelatin-modified calcium silicate cement with washout resistance

In Vitro Physiochemical Properties of A Biomimetic Gelatin/Chitosan Oligosaccharide/Calcium Silicate Cement

Physicochemical properties and biocompatibility of chitosan oligosaccharide/gelatin/calcium phosphate hybrid cements

Enhanced Antibacterial Activity of Calcium Silicate-Based Hybrid Cements for Bone Repair.

Anti-washout Carboxymethyl Chitosan Modified Tricalcium Silicate Bone Cement: Preparation, Mechanical Properties and in Vitro Bioactivity

Osteogenic Differentiation and Immune Response of Human Bone-Marrow-derived Mesenchymal Stem Cells on Injectable Calcium-Silicate-based Bone Grafts.

Immersion behavior of gelatin-containing calcium phosphate cement.

Novel fast-setting calcium silicate bone cements with high bioactivity and enhanced osteogenesis in vitro

In vitro physicochemical properties, osteogenic activity, and immunocompatibility of calcium silicate-gelatin bone grafts for load-bearing applications.

In vitro degradation and angiogenesis of the porous calcium silicate–gelatin composite scaffold

Characteristics of calcium sulfate/gelatin composite biomaterials for bone repair.

Acid-resistant calcium silicate-based composite implants with high-strength as load-bearing bone graft substitutes and fracture fixation devices.

A Bioactive Degradable Composite Bone Cement Based on Calcium Sulfate and Magnesium Polyphosphate

Calcium silicate/gelatin composite scaffolds with controllable degradation behavior: Fabrication and evaluation

Injectable pregelatinized corn starch reinforced calcium sulfate cement for bone defect repair

Preparation of a Novel Bone Wax with Modified Tricalcium Silicate Cement and BGs.

Calcium Sulfate Cement Combined With Silica-Based Mesoporous Material For Bone Regeneration: In Vitro And In Vivo Study

Synthesis of Pure Tricalcium Silicate Powder by the Pechini Method and Characterization of Hydrated Cement

In Vitro Degradability, Bioactivity And Primary Cell Responses To Bone Cements Containing Mesoporous Magnesium-Calcium Silicate And Calcium Sulfate For Bone Regeneration

In-situ hybridization of calcium silicate and hydroxyapatite-gelatin nanocomposites enhances physical property and in vitro osteogenesis